Weight loss can vary, depending on which GLP-1 drug you use and the dosage
The consent must accurately characterize the compound as an unapproved bulk drug substance (not as an approved drug used off-label), the evidence base and its limitations, known and theoretical risks, alternatives considered, the monitoring plan, and the patients ability to decline or discontinue
They will consider your health history, current medications, and personal goals to determine if its the right choice for you
GLP-1 medications start with low doses that gradually increase over weeks, meaning the full appetite-suppressing effect takes longer to develop
Additionally, it occupies GIP receptors and mimics the action of the GIP hormone to enhance insulin release and promote fat breakdown